Nufarm's Margin Recovery Story Looks Intact -- Market Talk

Dow Jones
Mar 06

2234 GMT - The latest commentary by competitors of Nufarm supports Bell Potter's buy call on the crop-chemicals supplier. "Recent peer reporting has highlighted continued margin recovery, with trade flows indicating a solid level of inventory rebuild ahead of major selling windows," analyst Jonathan Snape says. Bell Potter expects Nufarm's 1H to show a continuation of the margin recovery story that became evident in 2H of FY 2025 in its crop protection business. It also expects a material turnaround in Omega-3 earnings. "The foundations for 2H selling windows look positive with the potential for prolonged Middle East conflict to elevate crop protection pricing," the bank adds. It retains a A$3.60/share price target on Nufarm, which ended Thursday at A$2.09. (david.winning@wsj.com; @dwinningWSJ)

 

(END) Dow Jones Newswires

March 05, 2026 17:34 ET (22:34 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10